K(RW)3

General Information


DRACP ID  DRACP01854

Peptide Name   K(RW)3

Sequence  KRWRWRW

Sequence Length  7

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HT-29 Colon adenocarcinoma Carcinoma IC50=4.3 µM Crystal violet assay 48 h 1

Hemolytic Activity  Human erythrocytes: 50% Hemolysis=114 µM

Normal (non-cancerous) Cytotoxicity  Human fibroblasts: IC50=32.5 µM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP01854

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  C8

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C57H80N20O8

Absent amino acids  ACDEFGHILMNPQSTVY

Common amino acids  RW

Mass  128058

Pl  12.81

Basic residues  4

Acidic residues  0

Hydrophobic residues  3

Net charge  4

Boman Index  -4332

Hydrophobicity  -287.14

Aliphatic Index  0

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  16500

Absorbance 280nm  2750

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 24900420

Title  Tuning the activity of a short arg-trp antimicrobial Peptide by lipidation of a C- or N-terminal lysine side-chain

Doi 10.1021/ml300148v

Year  2012

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.